Microbiome And Immunity Conferences | Europe | Asia | Middle East | Canada | Japan | Australia | USA

Microbiome and Immunity

Influenza surveillance systems are essential for monitoring the spread, evolution, and impact of influenza viruses, enabling early outbreak detection and effective public health responses. By integrating genomic sequencing, molecular diagnostics, digital reporting platforms, and artificial intelligence, modern surveillance systems support vaccine strain selection, monitor antiviral resistance, and strengthen preparedness for seasonal epidemics and emerging pandemic threats. This track brings together researchers, clinicians, epidemiologists, public health experts, and policymakers to discuss the latest advances in influenza surveillance, forecasting, data sharing, and global disease control strategies.

Market Analysis: The global influenza surveillance systems market is valued at approximately USD 9.8 billion in 2025 and is projected to reach nearly USD 16.7 billion by 2030, expanding at a CAGR of 11.2% during the forecast period. Market growth is driven by increasing investments in pandemic preparedness, expanding genomic surveillance programs, widespread adoption of AI-enabled disease monitoring platforms, and continuous advancements in molecular diagnostics. North America remains the largest market due to its well-established surveillance infrastructure, while the Asia-Pacific region is expected to register the fastest growth, supported by rising healthcare investments, digital health initiatives, and enhanced influenza monitoring programs.

Tracks